News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
David Gandara: Jonathan Riess about impact of baseline positive vs negative plasma ctDNA
Photo collage of Jonathan Riess and David Gandara
Aug 27, 2024, 21:52

David Gandara: Jonathan Riess about impact of baseline positive vs negative plasma ctDNA

David Gandara, Co-Director-Center for Experimental Therapeutics at UC Davis Comprehensive Cancer Center, shared a post on X:

“At Cal Cancer Consortium conference, Jonathan Riess shows impact of baseline positive vs negative plasma ctDNA for EGFR in the FLAURA2 trial. Addition of chemo to Osi mainly benefitting those with positive ctDNA. Food for thought!”

David Gandara: Jonathan Riess about impact of baseline positive vs negative plasma ctDNA

Source: David Gandara/X

Cal Cancer Consortium cancer Cancer research chemotherapy ctDNA Impact David Gandara EGFR Experimental Therapeutics FLAURA2 Trial Jonathan Riess OncoDaily Oncology Oncology Conference osimertinib plasma ctDNA UC Davis Comprehensive Cancer Center
Insight
Aug 27, 2024, 22:17
One - Third of Indian Cancer Patients are over 60
Blog
Aug 27, 2024, 22:15
2-year diagnosis anniversary of Flora Gabtony
Insight
Aug 27, 2024, 22:13
Stephen Liu: Final anaysis of WJOG9717L
Insight
Aug 27, 2024, 22:11
Ruben Mesa: Grateful for our amazing MPN workshop North Carolina co-chairs
Insight
Aug 27, 2024, 22:10
Erman Akkus: Genome targeted cancer therapies in NCCN guidelines according to the ESMO MCBS and ESCAT
Insight
Aug 27, 2024, 22:07
Sarah Sammons: Expanding telehealth is a very important way to overcome disparities in healthcare access
Insight
Aug 27, 2024, 22:06
Giuseppe Banna: Promising results for Telisotuzumab Vedotin in advanced NSCLC
Insight
Aug 27, 2024, 22:04
How prostate cancer metabolism influences response to anti-androgen therapy
Insight
Aug 27, 2024, 22:03
Amir Horowitz: Treatment strategies and management of BCG-unresponsive NMIBC
Blog
Aug 27, 2024, 21:59
Hear about the translational aspects of Myeloproliferative neoplasms from Joseph Scandura - VJHemOnc
Blog
Aug 27, 2024, 21:52
David Gandara: Jonathan Riess about impact of baseline positive vs negative plasma ctDNA
Blog
Aug 27, 2024, 21:50
Noemi Reguart: Elevate your Science Communications during WCLC24